期刊文献+

系统性红斑狼疮患者使用皮质类固醇引起的并发损害与其剂量的相关性研究 被引量:2

Correlation study on complicated damages from side-effects and dosage of corticosteroid in systemic lupus erythematosus
暂未订购
导出
摘要 目的:评价系统性红斑狼疮(SLE)患者在使用皮质类固醇治疗中产生的并发损害及与其剂量的相关性。方法:用SLICC/ACRDamageIndex测量SLE活动及其治疗产生的损害,用Cox比例风险模式分析SLE损害同累积剂量、大剂量皮质类固醇和冲击治疗的相对危险度。结果:骨质疏松性骨折、冠状动脉疾病和白内障与泼尼松累积量相关,无菌性骨坏死和脑血管意外与使用大剂量皮质类固醇相关,慢性认知障碍与冲击治疗相关。结论:累积和大剂量泼尼松与SLE患者持久的器官损害呈显著性相关。 Objective: To evaluate the correlation between corticosteroid dosage and organ damages from steroid side-effects in patients with SLE. Methods: The occurrence and data of organ damage, as by SLICC/ACR Damage Index, were determined for 539 patients. The damage risk associated with cumulative prednisone dose, high-dose prednisone, and pulse methylprednisone was estimated by using regression analyses of Cox proportional hazards. Results: The cumulative prednisone dose was significantly associated with the development of osteoporotic fractures (RR 2.5), symptomatic coronary artery disease (RR 1.7), and cataracts (RR 1.9). Each 2-month exposure to high-dose prednisone was associated with a 1.2-fold increase in the risk of both vascular necrosis and stroke. Conclusions: SLE patients receiving long-term prednisone therapy were at high risk of morbidity due to permanent organ damages.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2003年第7期388-390,共3页 Journal of Clinical Dermatology
关键词 红斑狼疮 系统性 皮质类固醇 不良反应 器官损害 lupus erythematosus, systemic corticosteroids side effects organ damage
  • 相关文献

参考文献7

  • 1Nossent JC. SLICC/ACR Damage Index in Afro-Caribbean pa tients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis[J]. J Rheumatol, 1998, 25(4): 654-659.
  • 2Kipen Y, Buchbinder R, Forbes A, et al. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids[J]. J Rheumatol, 1997, 24(10): 1922-1929.
  • 3Li EK, Tam LS, Young RP, et al. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids[J]. Br J Rheumatol, 1998, 37(4): 405-410.
  • 4Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study[J]. Am J Epidemiol, 1997, 145(5): 408-415.
  • 5Esdaile JM, Abrahaowicz M, Grodzicky T, et al. Myocardial infarction and stroke in SLE: markedly increased incidence after controlling for risk factors[abstract][J]. Arthritis Rheum, 1998, 41(Suppl 9): S139.
  • 6Mok CC, Lau CS, Wong RW. Risk factors for avascular bone necrosis in systemic lupus erythematosus [J]. Br J Rheumatol,1998, 37(8): 895-900.
  • 7Salas M, Hofman A, Stricker BH. Confounding by indication: an example of variation in the use of epldemiologic terminology [J].Am J Epidemiol, 1999, 149(11): 981-983.

同被引文献21

  • 1张晓维,苏会敏,李保强.系统性红斑狼疮32例临床分析[J].临床荟萃,2004,19(24):1410-1411. 被引量:1
  • 2韩志华,何奔,邵琴,陆瑜,顾越英,葛恒,何清,龚兴荣,张清,厉锦华,王彬尧.系统性红斑狼疮合并急性冠状动脉综合征冠状动脉介入治疗临床分析[J].中华风湿病学杂志,2007,11(10):617-619. 被引量:1
  • 3Recio-Mayoral A, Mason JC, Kaski JC, et al. Chronic inflammation and coronary microvascular dysfunction in patients without risk fac- tors for coronary artery disease [ J ]. Eur Heart J, 2009,30 ( 15 ) : 1837-1g43.
  • 4Norby GE, Gfinther A, Mjcen G, et al. Prevalence and risk factors for coronary artery calcification following kidney transplantation for systemic lupus erythematosus [ J ]. Rheumatoiogy ( Oxford ), 2011, 50(9) :1659-1664.
  • 5Bulkley BH, Roberts WC. The heart in systemic lupus erythemato- sus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients [ J 1. Am J Med, 1975,58 (2) :243-264.
  • 6Orlacchio A, Bruce IN, Rahman P, et al. The apolipoprotein E2 iso- form is associated with accelerated onset of coronary artery disease in systemic lupus erythematosus[ J]. Med Sci Monit ,2008,14 (5) : CR233-CR237.
  • 7Rho YH, Solus J, Raggi P, et al. Maerophage activation and coro- nary atherosclerosis in systemic lupus erythematosus and rheuma- toid arthritis [ J ]. Arthritis Care Res ( Hoboken ), 2011,63 ( 4 ) : 535-541.
  • 8Bicakcigil M, Tasan D, Tasdelen N, et al. Role of fibrinolytic pa- rameters and plasminogen activator inhibitor 1 ( PAI-1 ) promoter polymorphism on premature atheroselerosis in SLE patients [ J ]. Lupus,2011,20(10) :1063-1071.
  • 9Kao AH, Wasko MC, Krishnaswami S,et al. C-reactive protein and coronary artery calcium in asymptomatic women with systemic lu- pus erythematosus or rheumatoid arthritis[ J]. Am J Car(lid ,2008, 102(6) :755-760.
  • 10Plazak W, Pasowicz M, Kostkiewicz M, et al. Influence of chronic inflammation and autoimmunity on coronary calcifications and myo- cardial perfusion defects in systemic lupus erythematosus patients J:. Inflamm Res ,20U ,60 (10) :973-980.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部